4.8 Review

Small extracellular vesicles in cancer

Journal

BIOACTIVE MATERIALS
Volume 6, Issue 11, Pages 3705-3743

Publisher

KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2021.03.015

Keywords

-

Funding

  1. Binghamton University Faculty Start-up Fund [910252-35]
  2. Binghamton University S3IP Award [ADLG195]
  3. National Cancer Institute [1R01CA23033901]

Ask authors/readers for more resources

Extracellular vesicles (EVs) are lipid-bilayer enclosed vesicles released from cells, carrying various molecules and playing crucial roles in tumors. EVs exhibit expression patterns similar to parental cells, aiding in early cancer diagnosis and treatment monitoring. In addition to research and diagnostics, EVs are utilized as drug delivery nanocarriers and therapeutic targets.
Extracellular vesicles (EV) are lipid-bilayer enclosed vesicles in submicron size that are released from cells. A variety of molecules, including proteins, DNA fragments, RNAs, lipids, and metabolites can be selectively encapsulated into EVs and delivered to nearby and distant recipient cells. In tumors, through such intercellular communication, EVs can regulate initiation, growth, metastasis and invasion of tumors. Recent studies have found that EVs exhibit specific expression patterns which mimic the parental cell, providing a fingerprint for early cancer diagnosis and prognosis as well as monitoring responses to treatment. Accordingly, various EV isolation and detection technologies have been developed for research and diagnostic purposes. Moreover, natural and engineered EVs have also been used as drug delivery nanocarriers, cancer vaccines, cell surface modulators, therapeutic agents and therapeutic targets. Overall, EVs are under intense investigation as they hold promise for pathophysiological and translational discoveries. This comprehensive review examines the latest EV research trends over the last five years, encompassing their roles in cancer pathophysiology, diagnostics and therapeutics. This review aims to examine the full spectrum of tumor-EV studies and provide a comprehensive foundation to enhance the field. The topics which are discussed and scrutinized in this review encompass isolation techniques and how these issues need to be overcome for EV-based diagnostics, EVs and their roles in cancer biology, biomarkers for diagnosis and monitoring, EVs as vaccines, therapeutic targets, and EVs as drug delivery systems. We will also examine the challenges involved in EV research and promote a framework for catalyzing scientific discovery and innovation for tumor-EV-focused research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available